These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1806610)

  • 1. Biochemical short-term changes produced by hormonal replacement therapy.
    Aloia JF; Vaswani A; Yeh JK; McGowan DM; Ross P
    J Endocrinol Invest; 1991 Dec; 14(11):927-34. PubMed ID: 1806610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of dietary calcium augmentation and hormone replacement therapy on bone turnover and serum levels of calcitrophic hormones.
    Aloia JF; Vaswani A; Yeh JK; Russo L
    Osteoporos Int; 1996; 6(1):55-62. PubMed ID: 8845601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination treatment with estrogen and calcitriol in the prevention of age-related bone loss.
    Gallagher JC; Fowler SE; Detter JR; Sherman SS
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3618-28. PubMed ID: 11502787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of a novel salmon calcitonin (sCT) technology-based oral formulation in healthy postmenopausal women: acute and 3-month effects on biomarkers of bone turnover.
    Tankó LB; Bagger YZ; Alexandersen P; Devogelaer JP; Reginster JY; Chick R; Olson M; Benmammar H; Mindeholm L; Azria M; Christiansen C
    J Bone Miner Res; 2004 Sep; 19(9):1531-8. PubMed ID: 15312255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is skeletal responsiveness to thyroid hormone altered in primary osteoporosis or following estrogen replacement therapy?
    Langdahl BL; Loft AG; Møller N; Weeke J; Eriksen EF; Mosekilde L; Charles P
    J Bone Miner Res; 1997 Jan; 12(1):78-88. PubMed ID: 9240729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salmon calcitonin in prevention of osteoporosis in maintenance dialysis patients.
    Wang SX; Li H
    Chin Med J (Engl); 2008 Jul; 121(14):1280-4. PubMed ID: 18713548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a short course of oral phosphate treatment on serum parathyroid hormone(1-84) and biochemical markers of bone turnover: a dose-response study.
    Brixen K; Nielsen HK; Charles P; Mosekilde L
    Calcif Tissue Int; 1992 Oct; 51(4):276-81. PubMed ID: 1422972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased serum osteocalcin levels in patients with postmenopausal osteoporosis.
    Pietschmann P; Resch H; Krexner E; Woloszczuk W; Willvonseder R
    Acta Med Austriaca; 1991; 18(5):114-6. PubMed ID: 1796722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of the selective oestrogen receptor modulator (raloxifene hydrochloride) on IL-6, TNF-alpha, TGF-beta1 and bone turnover markers in the treatment of postmenopausal osteoporosis.
    Ozmen B; Kirmaz C; Aydin K; Kafesciler SO; Guclu F; Hekimsoy Z
    Eur Cytokine Netw; 2007 Sep; 18(3):148-53. PubMed ID: 17823083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral 1,25-dihydroxyvitamin D administration in osteoporotic women: effects of estrogen therapy.
    Cosman F; Nieves J; Shen V; Lindsay R
    J Bone Miner Res; 1995 Apr; 10(4):594-600. PubMed ID: 7610930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute and 3-month effects of microcrystalline hydroxyapatite, calcium citrate and calcium carbonate on serum calcium and markers of bone turnover: a randomised controlled trial in postmenopausal women.
    Bristow SM; Gamble GD; Stewart A; Horne L; House ME; Aati O; Mihov B; Horne AM; Reid IR
    Br J Nutr; 2014 Nov; 112(10):1611-20. PubMed ID: 25274192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcitriol and calcium carbonate therapy in early chronic renal failure.
    Bianchi ML; Colantonio G; Campanini F; Rossi R; Valenti G; Ortolani S; Buccianti G
    Nephrol Dial Transplant; 1994; 9(11):1595-9. PubMed ID: 7870349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind, placebo-controlled, dose-finding trial of intermittent nasal salmon calcitonin for prevention of postmenopausal lumbar spine bone loss.
    Reginster JY; Deroisy R; Lecart MP; Sarlet N; Zegels B; Jupsin I; de Longueville M; Franchimont P
    Am J Med; 1995 May; 98(5):452-8. PubMed ID: 7733123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of bone loss by hormone replacement therapy is probably not due to stimulation of calcitonin secretion.
    Fletcher CD; Farish E; Leggate J; Hart DM
    Acta Endocrinol (Copenh); 1991 Apr; 124(4):353-6. PubMed ID: 2031433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of bone loss induced by thyroxine suppressive therapy in postmenopausal women: the effect of calcium and calcitonin.
    Kung AW; Yeung SS
    J Clin Endocrinol Metab; 1996 Mar; 81(3):1232-6. PubMed ID: 8772604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of low calcitonin doses on bone remodeling in postmenopausal women with high bone turnover rate].
    Campusano C; López JM; Campino C; Cárdenas I; Rojas A
    Rev Med Chil; 2000 Apr; 128(4):387-91. PubMed ID: 10962855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An evaluation of several biochemical markers for bone formation and resorption in a protocol utilizing cyclical parathyroid hormone and calcitonin therapy for osteoporosis.
    Hodsman AB; Fraher LJ; Ostbye T; Adachi JD; Steer BM
    J Clin Invest; 1993 Mar; 91(3):1138-48. PubMed ID: 8450043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteoporosis: new hope for the future.
    Masi L; Bilezikian JP
    Int J Fertil Womens Med; 1997; 42(4):245-54. PubMed ID: 9309458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of daily calcium and vitamin D supplementation on parathyroid hormone secretion.
    Reginster JY; Zegels B; Lejeune E; Micheletti MC; Taquet AN; Albert A
    Gynecol Endocrinol; 2001 Feb; 15(1):56-62. PubMed ID: 11293926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effects of calcium supplementation on serum parathyroid hormone level, bone turnover, and bone loss in elderly women.
    Riggs BL; O'Fallon WM; Muhs J; O'Connor MK; Kumar R; Melton LJ
    J Bone Miner Res; 1998 Feb; 13(2):168-74. PubMed ID: 9495509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.